drugset

drugset / Trial / NCT00174278

Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary

NCT00174278 ↗

Phase 3 Completed 14 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the effect of long-term treatment by Genotonorm on linear growth

Timeline

Start: 1997-02
Primary completion: —
Completion: 2006-10

Publications

David H, Aupiais C, Louveau B, Quartier P, Jacqz-Aigrain E, Carel JC, Simon D. Growth Outcomes After GH Therapy of Patients Given Long-Term Corticosteroids for Juvenile Idiopathic Arthritis. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4578-4587. doi: 10.1210/jc.2017-01455.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Somatropin	Protein / enzyme biologic	0.056 mg/kg	—

Indications